Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
What is the price performance of Diagnos Inc. stock?
The current price of Diagnos Inc. is $0.22, it has increased 4.76% in the last trading day.
What are the primary business themes or industries for DIAGNOS Inc.?
DIAGNOS Inc. belongs to Health Care industry and the sector is Health Care
What is DIAGNOS Inc. market cap?
DIAGNOS Inc.'s current market cap is $26.4M
Is DIAGNOS Inc. a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for DIAGNOS Inc., including 3 strong buy, 5 buy, 1 hold, 0 sell, and 3 strong sell